Cargando…
Interpreting serum procalcitonin in COVID-19 patients undergoing renal replacement therapy
Autores principales: | Adams, Briony, Beaney, Alec |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585560/ https://www.ncbi.nlm.nih.gov/pubmed/34775132 http://dx.doi.org/10.1016/j.jgar.2021.09.014 |
Ejemplares similares
-
Prognosis Factors of Patients Undergoing Renal Replacement Therapy
por: Muñoz-Terol, José Manuel, et al.
Publicado: (2023) -
Early Serum Procalcitonin Level after Primary Total Hip Replacement
por: Bouaicha, Samy, et al.
Publicado: (2013) -
Early prediction of renal parenchymal injury with serum procalcitonin
por: Barati, Leila, et al.
Publicado: (2016) -
Interpreting trials on renal replacement therapy initiation: beware of methodologic issues
por: Gaudry, Stéphane, et al.
Publicado: (2020) -
Vitamin D serum levels in multiorgan failure critically ill patients undergoing continuous renal replacement therapies
por: Czarnik, Tomasz, et al.
Publicado: (2020)